Autolymphocyte therapy in the treatment of metastatic renal cell carcinoma

I S Sawczuk

Autolymphocyte therapy in the treatment of metastatic renal cell carcinoma

Urol Clin North Am. 1993 May;20(2):297-301.

Author

I S Sawczuk¹

Affiliation

¹ Department of Urology, College of Physicians and Surgeons, Columbia University, New York, New York.

PMID: 8493751

Abstract

Autolymphocyte therapy is outpatient adoptive immunotherapy based on the infusion of ex vivo activated memory T cells. Autolymphocyte therapy has been used to treat more than 500 patients with renal cell carcinoma and the mechanism of action as well as the clinical outcome of data are reviewed.

Publication types

Review

MeSH terms

Carcinoma, Renal Cell / mortality
Carcinoma, Renal Cell / secondary*
Carcinoma, Renal Cell / therapy*
Female
Humans
Immunotherapy, Adoptive / methods*
Kidney Neoplasms / mortality
Kidney Neoplasms / therapy*
Lymphocyte Activation
Male
Middle Aged
Survival Rate
T-Lymphocytes / immunology*